We have previously shown that CpG methylation (CpG site covered by Infinium BeadChip bead cg08460026) of the co-localized CTLA4 gene predicts response to ICB in melanoma and clear cell renal cell carcinoma [21–23]. This evidence concerns the gene CTLA4 and clear cell renal carcinoma.